"Tom Abate's reporting on biotechnology has always been ahead of the times. The Biotech Investor tackles the brave new world of stem cells, genomics, and clones and comes up a winner." --Thom Calandra, editor in chief, CBS MarketWatch In The Biotech Investor , San Francisco Chronicle biotechnology reporter Tom Abate explains the science, finances, time horizon, and technological and commercial potential of this burgeoning industry. Abate provides guidelines for assessing company leadership, easy-to-digest reports ...
Read More
"Tom Abate's reporting on biotechnology has always been ahead of the times. The Biotech Investor tackles the brave new world of stem cells, genomics, and clones and comes up a winner." --Thom Calandra, editor in chief, CBS MarketWatch In The Biotech Investor , San Francisco Chronicle biotechnology reporter Tom Abate explains the science, finances, time horizon, and technological and commercial potential of this burgeoning industry. Abate provides guidelines for assessing company leadership, easy-to-digest reports from the labs, and indispensable investor tools and metrics. He shares strategies for - tracking the effect of breaking news and the NASDAQ - anticipating drug trial announcements and FDA approvals - assessing the potential market, patent rights, and distribution deals for a drug He looks beyond medicine to biotech-related opportunities in everything from agriculture to jean manufacturing to software development. The Biotech Investor is the comprehensive, expert source for successful and intelligent investing in one of the twenty-first century's most promising industries.
Read Less
Add this copy of The Biotech Investor: How to Profit From the Coming to cart. $3.18, very good condition, Sold by ThriftBooks-Dallas rated 5.0 out of 5 stars, ships from Dallas, TX, UNITED STATES, published 2004 by St. Martins Press-3PL.
Add this copy of The Biotech Investor: How to Profit From the Coming to cart. $3.18, good condition, Sold by ThriftBooks-Atlanta rated 5.0 out of 5 stars, ships from Austell, GA, UNITED STATES, published 2004 by St. Martins Press-3PL.
Add this copy of The Biotech Investor: How to Profit From the Coming to cart. $3.18, fair condition, Sold by ThriftBooks-Atlanta rated 5.0 out of 5 stars, ships from Austell, GA, UNITED STATES, published 2004 by St. Martins Press-3PL.
Add this copy of The Biotech Investor: How to Profit From the Coming to cart. $5.35, good condition, Sold by ThriftBooks-Reno rated 5.0 out of 5 stars, ships from Reno, NV, UNITED STATES, published 2003 by Times Books.
Add this copy of The Biotech Investor: How to Profit From the Coming to cart. $7.99, very good condition, Sold by HPB-Ruby rated 4.0 out of 5 stars, ships from Dallas, TX, UNITED STATES, published 2004 by Holt Paperbacks.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Very good. Connecting readers with great books since 1972! Used books may not include companion materials, and may have some shelf wear or limited writing. We ship orders daily and Customer Service is our top priority!
Add this copy of The Biotech Investor: How to Profit From the Coming to cart. $9.19, very good condition, Sold by Half Price Books Inc rated 4.0 out of 5 stars, ships from Dallas, TX, UNITED STATES, published 2004 by Holt Paperbacks.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Very good. Connecting readers with great books since 1972! Used books may not include companion materials, and may have some shelf wear or limited writing. We ship orders daily and Customer Service is our top priority!
Add this copy of The Biotech Investor: How to Profit From the Coming to cart. $12.10, new condition, Sold by Orion Tech rated 4.0 out of 5 stars, ships from Arlington, TX, UNITED STATES, published 2004 by Holt Paperbacks.
Add this copy of The Biotech Investor: How to Profit from the Coming to cart. $16.27, new condition, Sold by Ingram Customer Returns Center rated 5.0 out of 5 stars, ships from NV, USA, published 2004 by Holt Paperbacks.